One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Front Cover
Johnny T. K. Cheung MBChB, Aimin Yang PhD, Hongjiang Wu PhD, Eric S. H. Lau PhD, Juliana Lui PhD, Alice P. S. Kong MD, Ronald C. W. Ma MBChB, Andrea O. Y. Luk MD, Elaine Chow PhD, Juliana C. N. Chan MD
doi : 10.1111/dom.15818
Volume 26, Issue 8
Getting the measure of the pressure: Optimal assessment of the effects of glucagon-like peptide-1 receptor agonists on blood pressure
Karen L. Jones PhD, Chinmay S. Marathe PhD, Tongzhi Wu PhD, Christopher K. Rayner PhD, Michael Nauck MD, Michael Horowitz DSc
doi : 10.1111/dom.15631
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions
Hayase Hakariya PhD, Mutsuko Ohnishi MD, Tetsuya Tanimoto MD
doi : 10.1111/dom.15638
Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies
Megan Wilson BSc, Abdullah Al-Hamid PhD, Ismail Abbas PhD, Jason Birkett PhD, Iftikhar Khan PhD, Matthew Harper PhD, Dhiya Al-Jumeily OBE PhD, Sulaf Assi PhD
doi : 10.1111/dom.15593
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme
Richard M. Bergenstal MD, Athena Philis-Tsimikas MD, Carol Wysham MD, Molly C. Carr MD, Juliana M. Bue-Valleskey MS, Fady T. Botros PhD, Thomas Blevins MD, Julio Rosenstock MD
doi : 10.1111/dom.15604
Depression and type 2 diabetes: A causal relationship and mechanistic pathway
Wael Y. Khawagi PhD, Hayder M. Al-kuraishy PhD, Nawar R. Hussein PhD, Ali I. Al-Gareeb PhD, Esraa Atef PhD, Omnya Elhussieny PhD, Athanasios Alexiou PhD, Marios Papadakis PhD, Majid S. Jabir PhD, Abdullah A. Alshehri PhD, Hebatallah M. Saad PhD, Gaber El-Saber Batiha PhD … See fewer authorsÂ
doi : 10.1111/dom.15630
Obesity-induced tissue alterations resist weight loss: A mechanistic review
Lucio Della Guardia MD, Andrew C. Shin PhD
doi : 10.1111/dom.15637
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria
Afif Nakhleh MD, Muhammad Abdul-Ghani MD, Sivan Gazit MD, Adi Gross DVM, Idit Livnat PhD, Maya Greenbloom PhD, Adva Yarden MD, Khaled Khazim MD, Naim Shehadeh MD, Cheli Melzer Cohen MSc … See fewer authorsÂ
doi : 10.1111/dom.15623
A phase 1, randomized, double-blind, placebo-controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects
Panpan Xie MPharm, Morten T. Abildlund MSc, Tine A. Bækdal MSc, Xuemei He MD, Yassine K. Lyauk PhD, Usha Rani H. Patted MD, Zu Ning MD, Aixin Shi PhD
doi : 10.1111/dom.15624
Gastric emptying in newly diagnosed, treatment-naïve Han Chinese with type 2 diabetes and the impact of 4-week insulin pump therapy
Yixuan Sun MD, Yong Luo PhD, Chunjie Xiang PhD, Cong Xie PhD, Weikun Huang PhD, Zilin Sun PhD, Karen L. Jones PhD, Michael Horowitz PhD, Christopher K. Rayner PhD, Jianhua Ma PhD, Tongzhi Wu PhD … See fewer authorsÂ
doi : 10.1111/dom.15626
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study
Jenny Dimakos MD, Ying Cui MSc, Robert W. Platt PhD, Christel Renoux MD, Kristian B. Filion PhD, Antonios Douros MD
doi : 10.1111/dom.15627
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A retrospective nationwide claims database study in Japan
Mitsuhiro Shikamura MPharm, Atsushi Takayama PhD, Masato Takeuchi PhD, Koji Kawakami PhD
doi : 10.1111/dom.15632
Earlier detection of gestational diabetes impacts on medication requirements, neonatal and maternal outcomes
Omar Alberto Tirado-Aguilar MD, Nayeli Martinez-Cruz MD, Lidia Arce-Sanchez MD, Hector Borboa-Olivares PhD, Enrique Reyes-Muñoz PhD, Salvador Espino-y-Sosa MSc, Jose Rafael Villafan-Bernal PhD, Raigam Jafet Martinez-Portilla PhD, Guadalupe Estrada-Gutierrez PhD, Regina Uribe-Torres MD, Ricardo Daniel Tirado Aguilar MD, Maria Fernanda Lopez-Torres MD, Cecilia Ramos-Mendoza MD, Zaira Alexi Camacho-Martinez MD, Nelson Yesid Aguilar-Jaimes MD, Johnatan Torres-Torres MPH
doi : 10.1111/dom.15633
Gastric emptying is slower in women than men with type 2 diabetes and impacts on postprandial glycaemia
Chunjie Xiang MD, Yixuan Sun MD, Yong Luo PhD, Cong Xie PhD, Weikun Huang PhD, Karen L. Jones PhD, Michael Horowitz PhD, Zilin Sun PhD, Christopher K. Rayner PhD, Jianhua Ma PhD, Tongzhi Wu PhD
doi : 10.1111/dom.15635
Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists
David C. Klonoff MD, Sun H. Kim MD, Rodolfo J. Galindo MD, Jeffery I. Joseph DO, Valerie Garrett MD, Saurabh Gombar MD, Rachel E. Aaron BA, Tiffany Tian BA, David Kerr MBChB
doi : 10.1111/dom.15636
Pioglitazone reduces serum ketone bodies in sodium-glucose cotransporter-2 inhibitor-treated non-obese type 2 diabetes: A single-centre, randomized, crossover trial
Min Yang MD, Han Yue MD, Qinqin Xu MD, Shiying Shao MD, Yong Chen MD
doi : 10.1111/dom.15641
Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration
Sofia K. Konstantinidou MSc, Georgia Argyrakopoulou PhD, Stamatia Simati MD, Konstantinos Stefanakis MD, Alexander Kokkinos PhD, Antonis Analitis, Christos S. Mantzoros PhD
doi : 10.1111/dom.15642
Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studies
Clare Buckeridge PhD, Nikolaos Tsamandouras PhD, Santos Carvajal-Gonzalez PhD, Lisa S. Brown BS, Martha Hernandez-Illas MD, Aditi R. Saxena MD
doi : 10.1111/dom.15643
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN)
Tomoaki Morioka MD, Masakazu Takeuchi PhD, Akichika Ozeki PhD, Masanori Emoto MD
doi : 10.1111/dom.15644
Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide
Shanshan Hu MPharm, Chenyang Shi PharmD, Yuhang Ma MD, Shuowen Wang MPharm, Shengying Gu PharmD, Chendong Qi MPharm, Guorong Fan PharmD
doi : 10.1111/dom.15645
Frequency of prediabetes in individuals with increased adiposity and metabolically healthy or unhealthy phenotypes
Chiara M. A. Cefalo MD, Alessia Riccio MD, Elena Succurro MD, Maria Adelaide Marini MD, Teresa Vanessa Fiorentino MD, Mariangela Rubino MD, Maria Perticone MD, Angela Sciacqua MD, Francesco Andreozzi MD, Giorgio Sesti MD
doi : 10.1111/dom.15646
Validation of the Individualized Metabolic Surgery score in predicting long-term remission of diabetes after duodenal switch-type procedures
Sultan Almuallem MD, Abdulaziz Karam Ali MD, Phil Vourtzoumis MD, Sebastian Demyttenaere MD, Olivier Court MD, Amin Andalib MD
doi : 10.1111/dom.15647
Modelling and assessment of glucose-lactate kinetics in youth with overweight, obesity and metabolic dysfunction-associated steatotic liver disease: A pilot study
Jacopo Bonet PhD, Delaney Fox BS, Rafaela Nelson RD, Michael B. Nelson MD, Loretta Nelson MD, Cristina Fernandez MD, Emiliano Barbieri MD, Chiara Dalla Man PhD, Nicola Santoro MD
doi : 10.1111/dom.15648
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes
Cecilie H. Svensson MD, Therese W. Fabricius MD, Clementine E. M. Verhulst MD, Peter L. Kristensen MD, Cees J. Tack MD, Simon R. Heller MD, Stephanie A. Amiel MD, Rory J. McCrimmon MD, Mark Evans MD, Jens J. Holst MD, Bastiaan E. de Galan MD, Ulrik Pedersen-Bjergaard MD, on behalf of the Hypo-RESOLVE consortium … See fewer authorsÂ
doi : 10.1111/dom.15649
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION-9, ORION-10 and ORION-11 Phase 3 randomized trials
Lawrence A. Leiter MD, Frederick J. Raal PhD, Gregory G. Schwartz MD, Wolfgang Koenig MD, Kausik K. Ray FMedSci, Ulf Landmesser MD, Jackie Han MS, Lorena Garcia Conde MD, R. Scott Wright MD
doi : 10.1111/dom.15650
Association between two novel anthropometric measures and type 2 diabetes in a Chinese population
Di Wang MPH, Ziting Chen MPH, Yinru Wu MSc, Jiaojiao Ren PhD, Dong Shen PhD, Guifang Hu PhD, Chen Mao PhD
doi : 10.1111/dom.15651
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
RECAP study group, Shunichiro Tsukamoto MD, Kazuo Kobayashi MD, Masao Toyoda MD, Atsuhito Tone MD, Daiji Kawanami MD, Daisuke Suzuki MD, Daisuke Tsuriya MD, Hideo Machimura MD, Hidetoshi Shimura MD, Hiromichi Wakui MD, Hiroshi Takeda MD, Hisashi Yokomizo MD, Kei Takeshita MD, Keiichi Chin MD, Keizo Kanasaki MD, Masaaki Miyauchi MD, Masuo Saburi MD, Miwa Morita MD, Miwako Yomota MD, Moritsugu Kimura MD, Nobuo Hatori MD, Shinichi Nakajima MD, Shun Ito MD, Takashi Murata MD, Takaya Matsushita MD, Takayuki Furuki MD, Takuya Hashimoto MD, Tomoya Umezono MD, Yoshimi Muta MD, Yuichi Takashi MD, Kouichi Tamura MD … See fewer authorsÂ
doi : 10.1111/dom.15652
Cardiometabolic factors and population risks of cardiovascular disease in community-dwelling adults with varied blood pressure statuses
Weida Qiu MD, Anping Cai MD, Zhiqiang Nie MD, Jiabin Wang MD, Yanqiu Ou MD, Yingqing Feng MD
doi : 10.1111/dom.15653
Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial
Kamel Mohammedi MD, Sibylle Hess PhD, Matthew McQueen MD, Marie Pigeyre MD, Shun Fu Lee PhD, Guillaume Pare MD, Hertzel C. Gerstein MD
doi : 10.1111/dom.15654
Metformin use associated with lower rate of hospitalization for influenza in individuals with diabetes
Elizabeth Greene MD, Cynthia L. Green PhD, Jillian Hurst PhD, Nancie J. MacIver MD
doi : 10.1111/dom.15655
A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes
Olivier Bourron MD, Kamel Mohammedi MD, Joe De Keizer MSc, Fabrice Schneider MD, Samy Hadjadj MD, Pierre-Jean Saulnier MD
doi : 10.1111/dom.15656
Development and first-stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes
Omri Segev BMedSc, Itamar Raz MD, Hertzel C. Gerstein MD, Hillel Aviezer PhD, Yael Sela PhD, Dani Cukierman MBA, Rahul Shankar BSc, Rachel Natovich PhD, Tali Cukierman-Yaffe MD
doi : 10.1111/dom.15657
Effects of gut microbiome on type 1 diabetes susceptibility and complications: A large-scale bidirectional Mendelian randomization and external validation study
Keyu Guo MD, Jianan Ye MD, Jiaqi Li MD, Juan Huang MD, Zhiguang Zhou MD
doi : 10.1111/dom.15658
Cross-sectional association of continuous glucose monitoring-derived metrics with cerebral small vessel disease in older adults with type 2 diabetes
Taiki Sugimoto PhD, Naoki Saji MD, Takuya Omura MD, Haruhiko Tokuda MD, Hisayuki Miura MD, Shuji Kawashima MD, Takafumi Ando PhD, Akinori Nakamura MD, Kazuaki Uchida PhD, Nanae Matsumoto PhD, Kosuke Fujita PhD, Yujiro Kuroda PhD, Paul K. Crane MD, Takashi Sakurai MD … See fewer authorsÂ
doi : 10.1111/dom.15659
The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: A propensity score-matched analysis
Gwyneth Kong MBBS, Grace Cao MBBS, Jaycie Koh MBBS, Siew Pang Chan PhD, Audrey Zhang MBBS, Esther Wong MBBS, Bryan Chong MBBS, Silingga Metta Jauhari PhD, Jiong-Wei Wang PhD, Anurag Mehta MD, Gemma A. Figtree MBBS, Mamas A. Mamas MBChB, Gavin Ng MBBS, Koo Hui Chan MBBS, Ping Chai MBBS, Adrian F. Low MBBS, Chi Hang Lee MBBS, Tiong Cheng Yeo MBBS, James Yip MBBS, Roger Foo MBBS, Huay Cheem Tan MBBS, Daniel Q. Huang MBBS, Mark Muthiah MBBS, Mark Yan-Yee Chan PhD, Poay-Huan Loh MBChB, Nicholas W. S. Chew MBChB
doi : 10.1111/dom.15660
Association of dipeptidyl peptidase-4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability
Johnny T. K. Cheung MBChB, Aimin Yang PhD, Hongjiang Wu PhD, Eric S. H. Lau PhD, Juliana Lui PhD, Alice P. S. Kong MD, Ronald C. W. Ma MBChB, Andrea O. Y. Luk MD, Elaine Chow PhD, Juliana C. N. Chan MD
doi : 10.1111/dom.15662
Long-term changes in frailty and incident type 2 diabetes: A prospective cohort study based on the UK Biobank
Ying Sun MD, Weihao Li MD, Yinuo Zhou MD, Bin Wang PhD, Xiao Tan PhD, Yingli Lu MD, Jingjing Zhu MD, Wentao Shi PhD, Ningjian Wang MD
doi : 10.1111/dom.15676
Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes
Ying He PhD, Setor K. Kunutsor PhD, Andrew P. Kingsnorth PhD, Clare Gillies PhD, Pratik Choudhary MBBS, Kamlesh Khunti PhD, Francesco Zaccardi PhD
doi : 10.1111/dom.15677
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial
Navdeep Tangri MD, Thomas W. Ferguson MSc, Ryan J. Bamforth MSc, Silvia J. Leon MSc, Clare Arnott MD, Kenneth W. Mahaffey MD, Sradha Kotwal MD, Hiddo J. L. Heerspink MD, Vlado Perkovic MD, Robert A. Fletcher MSc, Brendon L. Neuen MD
doi : 10.1111/dom.15678
Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population
Adam Buckley PhD, Sara Suliman PhD, Matthew Allum MD, Nagi Mohammed MD, Nader Lessan MD, Carel W. le Roux PhD, Mohamed Suliman MD
doi : 10.1111/dom.15680
Cumulative effect of metabolic risk factors on left ventricular geometry in those with versus without early-onset type 2 diabetes or prediabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) study
Yilin Yoshida PhD, Yuanhao Zu MS, Bingbing Fan PhD, Shengxu Li MD, Tadashi Yoshida PhD, Emily Harville PhD, Tao Zhang PhD, Sejong Bae PhD, James Shikany DrPH, Vivian A. Fonseca MD
doi : 10.1111/dom.15681
Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes
Melissa R. Riester PharmD, Andrew R. Zullo PharmD, Richa Joshi MS, Lori A. Daiello PharmD, Kaleen N. Hayes PharmD, Darae Ko MD, Dae Hyun Kim MD, Medha Munshi MD, Sarah D. Berry MD
doi : 10.1111/dom.15682
Moderate resistance training reduces intermuscular adipose tissue and risk factors of atherosclerotic cardiovascular disease for elderly patients with type 2 diabetes
Fangli Tang MS, Wenjun Wang PhD, Ying Wang MS, Yaujiunn Lee PhD, Qingqing Lou MD
doi : 10.1111/dom.15684
Plasma fatty acid esters of hydroxy fatty acids and surrogate fatty acid esters of hydroxy fatty acids hydrolysis activity in children with or without obesity and in adults with or without coronary artery disease
Sze Min Ong BSc, Daniel Zhi Wei Ng BSc, Thaddeus En Zhe Chee, Andrew Anjian Sng MBBS, Chew Kiat Heng PhD, Yung Seng Lee MBBS, Eric Chun Yong Chan PhD, Delicia Shu Qin Ooi PhD
doi : 10.1111/dom.15686
Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin
Jianglan Long MD, Qiushi Fang MS, Zhe Shi MS, Zenghui Miao MS, Dan Yan MD
doi : 10.1111/dom.15689
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof-of-concept results from the DECIDE-CV clinical programme
Pedro Marques MD, Thomas A. Mavrakanas MD, Julian Guida BSc, Tara Gédéon MD, Anahita Emami MD, Abdulkhaliq Alaamiri MD, Daniel Ho MD, Elite Possik PhD, Guang Zhang MSc, Michael A. Tsoukas MD, Abhinav Sharma MD … See fewer authorsÂ
doi : 10.1111/dom.15691
Human adipose tissue expression of uncoupling protein 1 in response to intravenous administration of B-type natriuretic peptide hormone: Results from a randomized controlled crossover study
Katherine N. Bachmann MD, Ryan P. Ceddia PhD, Deepak K. Gupta MD, Sheila Collins PhD, Thomas J. Wang MD
doi : 10.1111/dom.15628
Real-world data from first UK Omnipod 5 users: A single-centre observational study
Aisha Aslam MRCP(UK), Alyson Chapman RN, Andrea Urwin RN, Sheetal Ohol RN, Sonia Thomas RN, Rebecca Gough RN, Lynne-Ann Findlow RN, Jonathan Lim PhD, Jonathan Schofield PhD, Lalantha Leelarathna PhD, Hood Thabit PhD … See fewer authorsÂ
doi : 10.1111/dom.15629
Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes
Sarra Smati MD, Thibaud Sotin MSc, Perrine Deniel MSc, Simon Ducheix PhD, Michael Joubert MD, Lucie Arnaud BA, Samy Hadjadj MD, Bertrand Cariou MD, Cédric Le May PhD, Xavier Prieur PhD
doi : 10.1111/dom.15634
A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study)
Akihiro Takahashi MD, Hiroshi Nomoto MD, Kinnosuke Onishi MD, Satoru Manda MD, Aika Miya MD, Hiraku Kameda MD, Akinobu Nakamura MD, Tatsuya Atsumi MD
doi : 10.1111/dom.15639
Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians
Mayer B. Davidson MD, S. Joshua Davidson BA
doi : 10.1111/dom.15679
Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial
Ayodele Odutayo MD, Francesco Cosentino MD, Richard E. Pratley MD, Samuel Dagogo-Jack MD, Darren K. McGuire MD, Robert Frederich MD, Wei Fu ScM, Christopher P. Cannon MD, David Z. I. Cherney MD, VERTIS CV Investigators … See fewer authorsÂ
doi : 10.1111/dom.15687
Impact of the basal/bolus ratio on continuous glucose monitoring parameters in patients with type 1 diabetes
Tomás González-Vidal MD, Diego Rivas-Otero MD, Guillermo Ramos-Ruiz MD, Pablo Agüeria-Cabal MD, Carmen Lambert PhD, Jessica Ares PhD, ElÃas Delgado PhD, Edelmiro Menéndez-Torre PhD
doi : 10.1111/dom.15690
The daunting task of recruiting insulin-treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions
Cathy J. Sun, Élisabeth Nguyen, Marc Prentki PhD, Rémi Rabasa-Lhoret
doi : 10.1111/dom.15688
